Page last updated: 2024-11-04

risedronic acid and Osteolysis

risedronic acid has been researched along with Osteolysis in 2 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamada, H1
Matsuo, A1
Koizumi, T1
Satomi, T1
Chikazu, D1
Mundy, GR1

Reviews

1 review available for risedronic acid and Osteolysis

ArticleYear
Bisphosphonates as cancer drugs.
    Hospital practice (1995), 1999, May-15, Volume: 34, Issue:5

    Topics: Antineoplastic Agents; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Neoplasm Proteins; Ne

1999

Other Studies

1 other study available for risedronic acid and Osteolysis

ArticleYear
A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography.
    Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014, Volume: 42, Issue:6

    Topics: Administration, Intravenous; Administration, Oral; Alendronate; Alveolar Process; Bisphosphonate-Ass

2014